Helperby Therapeutics is a pioneering brand that is dedicated to combating the global issue of antibiotic resistance. They are focused on developing combinations of approved antibiotics to reduce the risk of future resistance. With a strong emphasis on antibiotic stewardship, Helperby Therapeutics aims to provide innovative solutions to infectious diseases.

The alarming rise of antibiotic resistance poses a significant threat to global health, food security, and development. Each year, millions of people are infected with antibiotic-resistant bacteria, leading to thousands of deaths. Helperby Therapeutics acknowledges this urgent crisis and offers a radical approach to tackle it.

Through their research and development pipeline, Helperby Therapeutics is working towards finding effective solutions for infections that are becoming increasingly difficult to treat. By utilizing antibiotic combinations and implementing comprehensive antibiotic stewardship programs, they strive to combat the growing threat of antibiotic resistance. To support their mission, Helperby Therapeutics has opened a new round of fundraising.

By investing in this brand, individuals and organizations can contribute to the fight against antibiotic resistance and help shape a healthier future for everyone